Vitaspring Biomedical Changes Auditors
| Field | Detail |
|---|---|
| Company | Vitaspring Biomedical Co. Ltd. |
| Form Type | 8-K |
| Filed Date | Aug 25, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
TL;DR
Vitaspring Biomedical just fired its auditor, Weinberg & Company, P.A. No new one named yet.
AI Summary
Vitaspring Biomedical Co. Ltd. announced on August 19, 2025, a change in its certifying accountant. The company has dismissed its previous independent registered public accounting firm, Weinberg & Company, P.A., effective August 19, 2025. Vitaspring Biomedical has not yet appointed a new independent registered public accounting firm.
Why It Matters
A change in auditors can sometimes signal underlying issues with financial reporting or internal controls, or it could be a routine business decision.
Risk Assessment
Risk Level: medium — A change in auditors, especially without a replacement immediately identified, can raise concerns about financial reporting and internal controls.
Key Players & Entities
- VITASPRING BIOMEDICAL CO. LTD. (company) — Registrant
- Weinberg & Company, P.A. (company) — Dismissed Certifying Accountant
- August 19, 2025 (date) — Date of Accountant Change
- Donald P. Hateley, Esq. (person) — Contact Person
- The Hateley Firm, APC (company) — Legal Counsel
FAQ
When was the decision to change the certifying accountant made?
The change in certifying accountant was effective August 19, 2025.
Who was Vitaspring Biomedical's previous certifying accountant?
The previous certifying accountant was Weinberg & Company, P.A.
Has Vitaspring Biomedical appointed a new certifying accountant?
No, Vitaspring Biomedical has not yet appointed a new independent registered public accounting firm.
What is the effective date of the dismissal of the former accountant?
The dismissal of Weinberg & Company, P.A. was effective August 19, 2025.
What is Vitaspring Biomedical's state of incorporation?
Vitaspring Biomedical Co. Ltd. is incorporated in Nevada.
Filing Stats: 735 words · 3 min read · ~2 pages · Grade level 12.6 · Accepted 2025-08-25 12:01:53
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value VSBC None Indicate by che
Filing Documents
- vitaspring_8k.htm (8-K) — 25KB
- 0001683168-25-006448.txt ( ) — 188KB
- vsbc-20250819.xsd (EX-101.SCH) — 3KB
- vsbc-20250819_lab.xml (EX-101.LAB) — 33KB
- vsbc-20250819_pre.xml (EX-101.PRE) — 22KB
- vitaspring_8k_htm.xml (XML) — 4KB
01. Changes in Registrant's Certifying Accountant
ITEM 4.01. Changes in Registrant's Certifying Accountant. On August 19, 2025, the Board of Directors of VitaSpring Biomedical Co., Ltd. (the "Company") approved the engagement of JP Centurion & Partners PLT ("JP Centurion") as the Company's independent registered public accounting firm, effective as of such date. JP Centurion is a public accounting firm registered with the Public Company Accounting Oversight Board (PCAOB). The firm has been engaged to audit the Company's consolidated financial During the Company's two most recent fiscal years and the subsequent interim period through August 19, 2025, neither the Company nor anyone acting on its behalf has consulted with JP Centurion regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements, and no written report or oral advice was provided to the Company by JP Centurion that was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue; or (ii) any matter that was the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K) or a reportable event (as described in Item 304(a)(1)(v) of Regulation S-K). As previously disclosed in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 7, 2025, the Company reported the resignation of its former independent registered public accounting firm. This Current Report on Form 8-K is limited to the engagement of JP Centurion.
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K contains forward-looking review services to be performed. These statements are subject to risks and uncertainties that could cause actual outcomes to differ materially, including the timing and completion of audit and review procedures, the auditor's ability to complete its work as planned, and other factors beyond the Company's control. The Company undertakes no obligation to update any forward-looking statements, except as required by applicable law. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunder duly authorized. Date: August 25, 2025 VITASPRING BIOMEDICAL CO. LTD. By: /s/ Ssu-Chuan Lai Name: Ssu-Chuan Lai Title: Chairperson, Chief Executive Officer, and Chief Financial Officer 3